Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders

Clinical trial NCT02823210 · UNKNOWN

Trial details

NCT number: NCT02823210
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Study type: OBSERVATIONAL

Myeloproliferative Neoplasms

Start date: 2016-06-01
Primary completion: 2019-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.